About
StaniPharm is a contract development and manufacturing organization (CDMO) that develops and GMP-manufactures pharmaceutical and life-science products using supercritical CO2 technologies and nanosizing techniques, including nanoformulations, nanosized APIs, botanical extracts, and purification of polymers and lipids for clinical and commercial use.
Explore StaniPharm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.